Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction.

Hunter Wessells1, Geoffrey F Joyce, Matthew Wise

  • 1Department of Urology, University of Washington School of Medicine, Seattle, Washington 98104, USA. wessells@u.washington.edu

The Journal of Urology
|April 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention.

Lancet (London, England)·2026
Same author

Postoperative Symptom Severity and Time Course After Bilateral Ureteroscopy With Stents: Results From the Study to Enhance Understanding of Stent-associated Symptoms.

Urology·2025
Same author

Basic science and translational research: recommendations from the Fifth International Consultation for Sexual Medicine (ICSM 2024).

Sexual medicine reviews·2025
Same author

Increased body mass index is associated with recurrence and complications following repair for adult acquired buried penis.

The journal of sexual medicine·2025
Same author

An Overview of Farm Investigation Findings Associated with Outbreaks of Shiga Toxin-Producing Escherichia coli Infections Linked to Leafy Greens: 2009-2021.

Journal of food protection·2025
Same author

Reply by Authors.

The Journal of urology·2025
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
Same journal

With great cost comes great responsibility: who will own the rising costs of bladder cancer care?

The Journal of urology·2026
See all related articles

Erectile dysfunction affects nearly 20% of men, increasing with age and certain health conditions. Treatment costs could reach $15 billion nationwide, highlighting a growing public health concern.

Area of Science:

  • Urology
  • Public Health
  • Health Economics

Background:

  • Male sexual health is increasingly critical due to an aging US population and rising chronic conditions.
  • Erectile dysfunction (ED) significantly impacts men's health, necessitating a thorough understanding of its scope.
  • Interventions for various medical conditions can also affect male sexual function.

Purpose of the Study:

  • To characterize the disease burden and severity of erectile dysfunction (ED).
  • To analyze treatment patterns for ED.
  • To assess the economic consequences associated with ED.

Main Methods:

  • Utilized previously described analytical methods for data generation.
  • Analyzed self-reported data on ED prevalence.

Related Experiment Videos

  • Examined healthcare utilization and treatment trends.

    • Main Results:

    • Nearly 1 in 5 men reported ED, with prevalence increasing with age.
    • Higher ED rates were observed in Hispanic men and those with diabetes, obesity, smoking, or hypertension.
    • While diagnostic test use decreased, oral phosphodiesterase-5 inhibitor use and penile implant surgeries increased; healthcare costs could reach $15 billion.

    Conclusions:

    • The burden of ED in the US is projected to rise due to population aging and increased comorbidity.
    • Understanding ED pathogenesis, treatment-seeking behaviors, and patient preferences is crucial for accurate economic impact assessment.
    • Further research into treatment success and patient satisfaction is needed to manage the growing economic and health implications of ED.